Breaking Finance News

A statement released earlier today by Jefferies International about IP Group PLC (LON:IPO) maintains the target price at 175.00GBX

Jefferies International hold steady the target of IP Group PLC (LON:IPO) at 175.00GBX stating a potential upside of 0%.

On 05/25/2017, Jefferies International released a statement for IP Group PLC (LON:IPO) bumped up the target price from 169.00GBX to 175.00GBX that suggested an upside of 0.21%.

Boasting a price of 0.00GBX, IP Group PLC (LON:IPO) traded 0.74% higher on the day. With the last stock price close down -11.75% from the two hundred day average, compared with the S&P 500 Index which has increased 0.04% over the date range. IP Group PLC has recorded a 50-day average of 128.75GBX and a two hundred day average of 139.60GBX. Volume of trade was up over the average, with 936,462 shares of IPO changing hands over the typical 525,435

Performance Chart


With a total market value of 0 GBX, IP Group PLC has price-earnings ratio of 20.88 with a one year low of 109.10GBX and a one year high of 200.80GBX .

A total of 2 equity analysts have released a ratings update on IPO. Two equity analysts rating the company a strong buy, zero equity analysts rating the company a buy, zero equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of 284.50GBX.

Brief Synopsis About IP Group PLC (LON:IPO)

IP Group plc (IP Group) is a United Kingdom-based intellectual property commercialization company. The Company develops intellectual property-based businesses. The Company operates through three business segments: University partnership business, Venture capital fund management and In-licensing activity. The Company's University partnership business segment is engaged in the commercialization of intellectual property through the formation of long-term partner relationships with universities. The Company's Venture capital fund management segment is engaged in the management of venture funds focusing on the United Kingdom's early stage technology companies. The Company's In-licensing activity segment is engaged in the in-licensing of drugable intellectual property from research institutions. The Company's portfolio includes holdings in approximately 90 early stage businesses across over four main sectors, which include biotech, cleantech, healthcare and technology.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.